Ardelyx
ARDX
C$5.81
Share price
-1.40%
Change (1 day)
-24.54%
Change (1 year)
Categories
P/S ratio for Ardelyx (ARDX)
P/S ratio as of July 2025 (TTM): 2.79
According to Ardelyx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.93. At the end of 2025 the company had a P/S ratio of 3.25.
P/S ratio history for Ardelyx from 2014 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 3.25 | -12.17% |
| 2024 | 3.70 | -68.01% |
| 2023 | 11.6 | 12.9% |
| 2022 | 10.2 | -16.6% |
| 2021 | 12.3 | -84.64% |
| 2020 | 80.0 | -36.63% |
| 2019 | 126 | 194.05% |
| 2018 | 42.9 | 474.64% |
| 2017 | 7.47 | |
| 2016 | N/A | -100% |
| 2015 | 19.6 | 76.35% |
| 2014 | 11.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.55 | -44.37% | 🇺🇸 USA |
 Amgen AMGN | 4.78 | 71.35% | 🇺🇸 USA |
 Sanofi SNY | 2.56 | -8.21% | 🇫🇷 France |
 Abbott Laboratories ABT | 5.26 | 88.43% | 🇺🇸 USA |
 AstraZeneca AZN | 4.24 | 51.80% | 🇬🇧 UK |